Dr. Martin Holst Lange is Executive Vice President, Development, and member of the Executive Management at Novo Nordisk A/S. He joined Novo Nordisk in 2002 where he held various positions within the medical and clinical development functions in Denmark and in the US. @In January 2018, he was appointed Senior Vice President for Global Development, assuming the overall clinical development responsibilities of the Novo Nordisk pipeline. In March 2021, Dr Lange was appointed Executive Vice President for Development.